Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Takeda describes preclinical profile of GnRH antagonist TAK-385

Aug. 25, 2009

New Levitra formulation submitted for registration in E.U.

Aug. 25, 2009

Novel hypoxia-inducible factor inhibitors reported by FibroGen

Aug. 25, 2009

Taspoglutide improves glycemic control in patients unresponsive to metformin

Aug. 24, 2009

Wellstat Therapeutics claims compounds for treating type 2 diabetes

Aug. 24, 2009

Novel compounds for menopausal syndrome and oral contraception claimed by Bayer Schering Pharma

Aug. 24, 2009

Phase II trial of NeoFuse in lumbar spinal fusion surgery cleared by FDA

Aug. 21, 2009

Aska Pharmaceuticals describes novel PPAR activators

Aug. 21, 2009

11beta-HSD1 inhibitors for metabolic syndrome reported by Wyeth

Aug. 21, 2009

Cathepsin K inhibitors identified at Amura for treating bone disorders

Aug. 20, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...